Liquidation

Fresh Tracks Therapeutics Announces Listing on OTC Pink Market

Retrieved on: 
Tuesday, December 19, 2023

BOULDER, Colo., Dec. 19, 2023 (GLOBE NEWSWIRE) -- Fresh Tracks Therapeutics, Inc. (OTC Pink: FRTX) (“Fresh Tracks” or the “Company”) announced today that the Company’s common stock was suspended from trading on The Nasdaq Capital Market at the open of business.

Key Points: 
  • BOULDER, Colo., Dec. 19, 2023 (GLOBE NEWSWIRE) -- Fresh Tracks Therapeutics, Inc. (OTC Pink: FRTX) (“Fresh Tracks” or the “Company”) announced today that the Company’s common stock was suspended from trading on The Nasdaq Capital Market at the open of business.
  • Fresh Tracks cautions that these forward-looking statements are subject to numerous assumptions, risks, and uncertainties, which change over time, often quickly, and in unanticipated ways.
  • The forward-looking statements represent the estimates of Fresh Tracks as of the date hereof only.
  • Fresh Tracks specifically disclaims any duty or obligation to update forward-looking statements.

Fresh Tracks Therapeutics Announces its Common Stock will be Suspended from Trading on Nasdaq at Open of Business on December 19th

Retrieved on: 
Monday, December 18, 2023

BOULDER, Colo., Dec. 18, 2023 (GLOBE NEWSWIRE) -- Fresh Tracks Therapeutics, Inc. (Nasdaq: FRTX) (“Fresh Tracks” or the “Company”) announced today receipt of a notice from Nasdaq stating that the Company’s common stock will be suspended from trading on The Nasdaq Capital Market at the open of business on December 19, 2023.

Key Points: 
  • BOULDER, Colo., Dec. 18, 2023 (GLOBE NEWSWIRE) -- Fresh Tracks Therapeutics, Inc. (Nasdaq: FRTX) (“Fresh Tracks” or the “Company”) announced today receipt of a notice from Nasdaq stating that the Company’s common stock will be suspended from trading on The Nasdaq Capital Market at the open of business on December 19, 2023.
  • Following the suspension, the Company expects its common stock to begin trading on an over-the-counter market.
  • The Company anticipates disclosing further trading market information for its common stock once such information becomes available.
  • The forward-looking statements represent the estimates of Fresh Tracks as of the date hereof only.

Fresh Tracks Therapeutics Announces Third Adjournment of Special Meeting of Stockholders

Retrieved on: 
Friday, December 15, 2023

BOULDER, Colo., Dec. 15, 2023 (GLOBE NEWSWIRE) -- Fresh Tracks Therapeutics, Inc. (Nasdaq: FRTX) (“Fresh Tracks” or the “Company”) announced today that its special meeting of stockholders (the “Special Meeting”), which was previously adjourned on November 16, 2023 and November 30, 2023, has been adjourned for a third time to Wednesday, December 27, 2023 at 10 a.m. Mountain Time with respect to both proposals described in Fresh Tracks’ definitive proxy statement filed with the U.S. Securities and Exchange Commission (the “SEC”) on October 20, 2023 (the “Proxy Statement”).

Key Points: 
  • In addition, the record date for determining stockholders entitled to vote at the Special Meeting will remain the close of business on October 17, 2023.
  • During the current adjournment, Fresh Tracks continues to solicit votes from its stockholders with respect to both proposals set forth in the Proxy Statement.
  • Proxies previously submitted with respect to the Special Meeting will be voted on both proposals at the reconvened Special Meeting as indicated therein, unless properly revoked, and stockholders who have previously submitted a proxy need not take any action.
  • If Fresh Tracks’ stockholders do not approve Proposal 1, Fresh Tracks intends to seek judicial dissolution, which is likely to be costly and time-consuming and would reduce the amount of cash distributable to Fresh Tracks’ stockholders associated with the Company’s dissolution.

Thunder Bridge Capital Partners III, Inc. Announces its Intention to Liquidate

Retrieved on: 
Thursday, December 7, 2023

There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless.

Key Points: 
  • There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless.
  • All other costs and expenses associated with implementing the Dissolution will be funded from proceeds held outside of the Trust Account.
  • Beneficial owners of Public Shares held in “street name,” however, will not need to take any action in order to receive the Redemption Amount.
  • The Redemption Amount is expected to be paid out within ten business days of December 11, 2023.

Fresh Tracks Therapeutics Announces Second Adjournment of Special Meeting of Stockholders

Retrieved on: 
Friday, December 1, 2023

BOULDER, Colo., Dec. 01, 2023 (GLOBE NEWSWIRE) -- Fresh Tracks Therapeutics, Inc. (Nasdaq: FRTX) (“Fresh Tracks” or the “Company”) announced today that its special meeting of stockholders (the “Special Meeting”), which was previously adjourned on November 16, 2023, has been adjourned for a second time to Friday, December 15, 2023 at 10 a.m. Mountain Time with respect to both proposals described in Fresh Tracks’ definitive proxy statement filed with the U.S. Securities and Exchange Commission (the “SEC”) on October 20, 2023 (the “Proxy Statement”).

Key Points: 
  • In addition, the record date for determining stockholders entitled to vote at the Special Meeting will remain the close of business on October 17, 2023.
  • During the current adjournment, Fresh Tracks continues to solicit votes from its stockholders with respect to both proposals set forth in the Proxy Statement.
  • Proxies previously submitted with respect to the Special Meeting will be voted on both proposals at the reconvened Special Meeting as indicated therein, unless properly revoked, and stockholders who have previously submitted a proxy need not take any action.
  • If Fresh Tracks’ stockholders do not approve Proposal 1, Fresh Tracks intends to seek judicial dissolution, which is likely to be costly and time-consuming and would reduce the amount of cash distributable to Fresh Tracks’ stockholders associated with the Company’s dissolution.

FinServ Acquisition Corp. II Announces its Intention to Liquidate

Retrieved on: 
Tuesday, November 28, 2023

New York, New York, Nov. 28, 2023 (GLOBE NEWSWIRE) -- FinServ Acquisition Corp. II (“FinServ II”) (Nasdaq: FSRX) announced today that the board of directors of FinServ II (the “Board”) determined FinServ II cannot complete a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (a “Business Combination”) by February 22, 2024, the deadline by which FinServ II has to consummate such Business Combination under its Amended and Restated Certificate of Incorporation.

Key Points: 
  • New York, New York, Nov. 28, 2023 (GLOBE NEWSWIRE) -- FinServ Acquisition Corp. II (“FinServ II”) (Nasdaq: FSRX) announced today that the board of directors of FinServ II (the “Board”) determined FinServ II cannot complete a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (a “Business Combination”) by February 22, 2024, the deadline by which FinServ II has to consummate such Business Combination under its Amended and Restated Certificate of Incorporation.
  • There will be no redemption rights or liquidating distributions with respect to FinServ II’s warrants, which will expire worthless.
  • FinServ Holdings II, LLC, FinServ II’s sponsor, has agreed to waive its redemption rights with respect to the shares of FinServ II’s Class B common stock issued prior to the IPO, including shares of FinServ II’s Class A common stock issued upon conversion of such Class B common stock.
  • FinServ II thereafter intends to file a Form 15 with the Commission to suspend its reporting obligations under Sections 13 and 15(d) of the Exchange Act.

Fresh Tracks Therapeutics Announces Adjournment of Special Meeting of Stockholders

Retrieved on: 
Friday, November 17, 2023

BOULDER, Colo., Nov. 17, 2023 (GLOBE NEWSWIRE) -- Fresh Tracks Therapeutics, Inc. (Nasdaq: FRTX) (“Fresh Tracks” or the “Company”) announced today that its special meeting of stockholders (the “Special Meeting”) has been adjourned to Thursday, November 30, 2023 at 10 a.m. Mountain Time with respect to both proposals described in Fresh Tracks’ definitive proxy statement filed with the U.S. Securities and Exchange Commission (the “SEC”) on October 20, 2023 (the “Proxy Statement”).

Key Points: 
  • In addition, the record date for determining stockholders entitled to vote at the Special Meeting will remain the close of business on October 17, 2023.
  • During the current adjournment, Fresh Tracks continues to solicit votes from its stockholders with respect to both proposals set forth in the Proxy Statement.
  • Proxies previously submitted with respect to the Special Meeting will be voted on both proposals at the reconvened Special Meeting as indicated therein, unless properly revoked, and stockholders who have previously submitted a proxy need not take any action.
  • If Fresh Tracks’ stockholders do not approve Proposal 1, Fresh Tracks intends to seek judicial dissolution, which is likely to be costly and time-consuming and would reduce the amount of cash distributable to Fresh Tracks’ stockholders associated with the Company’s dissolution.

OPY Acquisition Corp I Announces Intent to Liquidate

Retrieved on: 
Monday, December 18, 2023

OPY Acquisition Corp I (NASDAQ: OHAA) (the “Company”) announced today that it will be unable to consummate an initial business combination and intends to dissolve and liquidate in accordance with the provisions of its Amended and Restated Certificate of Incorporation, as amended (“Liquidation”).

Key Points: 
  • OPY Acquisition Corp I (NASDAQ: OHAA) (the “Company”) announced today that it will be unable to consummate an initial business combination and intends to dissolve and liquidate in accordance with the provisions of its Amended and Restated Certificate of Incorporation, as amended (“Liquidation”).
  • To date, the Company made two monthly extensions to December 29, 2023.
  • The proceeds of the Trust Account will be held in a non-interest bearing account while awaiting disbursement to the holders of the Public Shares.
  • Beneficial owners of Public Shares held in “street name,” however, will not need to take any action in order to receive the redemption amount.

BlackRock Multi-Sector Opportunities Trust Announces Distribution

Retrieved on: 
Tuesday, December 5, 2023

The Board of Trustees of BlackRock Multi-Sector Opportunities Trust (the “Trust”) (CUSIP: 09190C104) announced today the Trust’s quarterly distribution, payable on December 29, 2023.

Key Points: 
  • The Board of Trustees of BlackRock Multi-Sector Opportunities Trust (the “Trust”) (CUSIP: 09190C104) announced today the Trust’s quarterly distribution, payable on December 29, 2023.
  • This distribution is considered a liquidating distribution under the Trust's Plan of Liquidation announced on November 15, 2023 .
  • The Trust expects to make periodic liquidating distributions to shareholders pursuant to the Plan of Liquidation in advance of its termination and to make a final liquidating distribution on or before February 29, 2024.
  • Upon the effectiveness of the Trust's Plan of Liquidation, the Automatic Dividend Reinvestment Plan of the Trust has been suspended with respect to any dividends or distributions declared on or after November 30, 2023.

Healthwell Acquisition Corp. I Announces Cancellation of Special Stockholder Meeting and its Intention to Liquidate

Retrieved on: 
Saturday, November 18, 2023

There will be no redemption rights or liquidating distributions with respect to Healthwell’s warrants, which will expire worthless.

Key Points: 
  • There will be no redemption rights or liquidating distributions with respect to Healthwell’s warrants, which will expire worthless.
  • All other costs and expenses associated with implementing the Dissolution will be funded from proceeds held outside of the Trust Account.
  • Beneficial owners of Public Shares held in “street name,” however, will not need to take any action in order to receive the Redemption Amount.
  • The Redemption Amount is expected to be paid out within ten business days after the instruction to Continental to commence the Redemption and Liquidation.